Paysign, headquartered in Nevada, USA, is a fully integrated provider of prepaid card products and processing services for corporate clients. The company operates in two primary business segments: plasma donor payments and pharmaceutical patient affordability programs.

Prepaid cards are the principal form of compensation for plasma donors in the USA. Annually, more than 50 million plasma donations are facilitated across over 1,000 collection centres nationwide. Paysign serves as the prepaid card provider for 478 of these centres, including many owned by Australia’s CSL.

In addition, Paysign manages patient affordability programs on behalf of major pharmaceutical companies, covering 66 specialty drugs. These programs, funded by pharmaceutical firms, assist patients in affording medications for which insurance covers only a partial cost.